PortalPublikationenContemporary prostate cancer prevalence among T1c biopsy-ref...

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter.

Standard

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter. / Ahyai, Sascha; Graefen, Markus; Steuber, Thomas; Haese, Alexander; Schlomm, Thorsten; Walz, Jochen; Köllermann, Jens; Briganti, Alberto; Zacharias, Mario; Friedrich, Martin; Karakiewicz, Pierre I; Montorsi, Francesco; Huland, Hartwig; Chun, Felix.

in: EUR UROL, Jahrgang 53, Nr. 4, 4, 2008, S. 750-757.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Ahyai, S, Graefen, M, Steuber, T, Haese, A, Schlomm, T, Walz, J, Köllermann, J, Briganti, A, Zacharias, M, Friedrich, M, Karakiewicz, PI, Montorsi, F, Huland, H & Chun, F 2008, 'Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter.', EUR UROL, Jg. 53, Nr. 4, 4, S. 750-757. <http://www.ncbi.nlm.nih.gov/pubmed/17964070?dopt=Citation>

APA

Ahyai, S., Graefen, M., Steuber, T., Haese, A., Schlomm, T., Walz, J., Köllermann, J., Briganti, A., Zacharias, M., Friedrich, M., Karakiewicz, P. I., Montorsi, F., Huland, H., & Chun, F. (2008). Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter. EUR UROL, 53(4), 750-757. [4]. http://www.ncbi.nlm.nih.gov/pubmed/17964070?dopt=Citation

Vancouver

Ahyai S, Graefen M, Steuber T, Haese A, Schlomm T, Walz J et al. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter. EUR UROL. 2008;53(4):750-757. 4.

Bibtex

@article{5412bab9df7b430699a1da830daa265d,
title = "Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter.",
abstract = "OBJECTIVE: To investigate the prostate cancer (PCa) prevalence and risk factors of men with prostate-specific antigen (PSA) level or =7. RESULTS: Overall PCa detection rate was 23.1%. The majority had a biopsy Gleason sum of 6 (79.5%) and 20.5% had a biopsy Gleason sum> or =7. Total PSA (tPSA) and percentage of free PSA (%fPSA) were statistically significantly different in men with and without PCa (all p or = 7 at biopsy, %fPSA and prostate volume represented independent and most informative risk factors. CONCLUSION: Our data demonstrate that a substantial percentage (23.1%) of men with a PSA<or =4.0 ng/ml and an unsuspicious DRE in a biopsy referral population harbor PCa, with 20.5% being high grade. Low %fPSA and low prostate volume represent important parameters in PCa and in high grade disease detection at biopsy, respectively.",
author = "Sascha Ahyai and Markus Graefen and Thomas Steuber and Alexander Haese and Thorsten Schlomm and Jochen Walz and Jens K{\"o}llermann and Alberto Briganti and Mario Zacharias and Martin Friedrich and Karakiewicz, {Pierre I} and Francesco Montorsi and Hartwig Huland and Felix Chun",
year = "2008",
language = "Deutsch",
volume = "53",
pages = "750--757",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level <or = 4.0 ng per milliliter.

AU - Ahyai, Sascha

AU - Graefen, Markus

AU - Steuber, Thomas

AU - Haese, Alexander

AU - Schlomm, Thorsten

AU - Walz, Jochen

AU - Köllermann, Jens

AU - Briganti, Alberto

AU - Zacharias, Mario

AU - Friedrich, Martin

AU - Karakiewicz, Pierre I

AU - Montorsi, Francesco

AU - Huland, Hartwig

AU - Chun, Felix

PY - 2008

Y1 - 2008

N2 - OBJECTIVE: To investigate the prostate cancer (PCa) prevalence and risk factors of men with prostate-specific antigen (PSA) level or =7. RESULTS: Overall PCa detection rate was 23.1%. The majority had a biopsy Gleason sum of 6 (79.5%) and 20.5% had a biopsy Gleason sum> or =7. Total PSA (tPSA) and percentage of free PSA (%fPSA) were statistically significantly different in men with and without PCa (all p or = 7 at biopsy, %fPSA and prostate volume represented independent and most informative risk factors. CONCLUSION: Our data demonstrate that a substantial percentage (23.1%) of men with a PSA<or =4.0 ng/ml and an unsuspicious DRE in a biopsy referral population harbor PCa, with 20.5% being high grade. Low %fPSA and low prostate volume represent important parameters in PCa and in high grade disease detection at biopsy, respectively.

AB - OBJECTIVE: To investigate the prostate cancer (PCa) prevalence and risk factors of men with prostate-specific antigen (PSA) level or =7. RESULTS: Overall PCa detection rate was 23.1%. The majority had a biopsy Gleason sum of 6 (79.5%) and 20.5% had a biopsy Gleason sum> or =7. Total PSA (tPSA) and percentage of free PSA (%fPSA) were statistically significantly different in men with and without PCa (all p or = 7 at biopsy, %fPSA and prostate volume represented independent and most informative risk factors. CONCLUSION: Our data demonstrate that a substantial percentage (23.1%) of men with a PSA<or =4.0 ng/ml and an unsuspicious DRE in a biopsy referral population harbor PCa, with 20.5% being high grade. Low %fPSA and low prostate volume represent important parameters in PCa and in high grade disease detection at biopsy, respectively.

M3 - SCORING: Zeitschriftenaufsatz

VL - 53

SP - 750

EP - 757

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 4

M1 - 4

ER -